Study of Diagnostic Performance of [18F]CTT1057 in BCR
Clinical trial NCT04838613 · COMPLETED
Trial details
- NCT number
- NCT04838613
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-11-23
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.